PM
Pranav Mittal
About Pranav Mittal
Data last updated:
Pranav Mittal is a Director at Simgrow Exim Private Limited (since 2022), Designated Partner at Singularis Research Llp (since 2025) and Director at Mitco Vaccines Private Limited (since 2025). The companies operate in Trading and Pharma. The largest current company by reported revenue is Simgrow Exim Private Limited at ₹45,000 (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 06 Jul 2022 | 2022 | ₹45,000 (FY 2025) | Active | |
| Designated Partner | 12 Sep 2025 | 2025 | Active | ||
| Director | 29 Apr 2025 | 2025 | Active |
Board colleagues of Pranav Mittal
| Name | DIN | Company | Designation |
|---|---|---|---|
| Bhawani Krishna Mittal | 09664797 | Simgrow Exim Private Limited , Mitco Vaccines Private Limited | Director |
| Ankush Midha | 11294916 | Singularis Research Llp | Designated Partner |
| Saurav | 11294917 | Singularis Research Llp | Designated Partner |
| Suman Mittal | 11081908 | Mitco Vaccines Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Pranav Mittal
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Pranav Mittal
Pranav Mittal currently holds 3 directorships: Simgrow Exim Private Limited (Director, since 06 Jul 2022, revenue ₹45,000 (FY 2025)); Singularis Research Llp (Designated Partner, since 12 Sep 2025); Mitco Vaccines Private Limited (Director, since 29 Apr 2025).
Pranav Mittal was first appointed on 06 Jul 2022 as Director at Simgrow Exim Private Limited. The most recent appointment on record is 12 Sep 2025 at Singularis Research Llp.
The current boards of Pranav Mittal's companies include Bhawani Krishna Mittal (Simgrow Exim Private Limited), Ankush Midha (Singularis Research Llp), Saurav (Singularis Research Llp), Suman Mittal (Mitco Vaccines Private Limited).